+25.5%
GSK vs CASY
+42.6%
-17.1%
-18.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CASY | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.7% | -3.0% | +0.3% | -2.5% |
| 7D | -4.2% | -4.4% | +0.2% | -3.9% |
| 30D | -7.5% | -12.0% | +4.5% | -6.9% |
| 3M | -3.3% | -2.3% | -0.9% | -3.5% |
| 6M | -9.3% | +10.5% | -19.9% | -11.0% |
| YTD | +1.6% | +33.0% | -31.4% | 0.0% |
| 1Y | +25.5% | +41.1% | -15.6% | +21.1% |
| All | +25.5% | +42.6% | -17.1% | +21.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CASY.
Daily Out/Under-Performance
Portfolio return minus CASY return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CASY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CASY wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling